Page last updated: 2024-09-05

desmethylselegiline and Parkinson Disease

desmethylselegiline has been researched along with Parkinson Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agid, Y; Olanow, CW; Schapira, AH1
Ahlner, J; Dizdar, N; Kronstrand, R; Larson, G1
Ikeda, N; Inoue, N; Itoh, S; Kudo, K; Nishida, K1
Bosc, M; Deffond, D; Dordain, G; Dostert, P; Fiorentini, F; La Croix, R; Persiani, S; Strolin Benedetti, M; Vernay, D1
Maruyama, W; Naoi, M1

Trials

2 trial(s) available for desmethylselegiline and Parkinson Disease

ArticleYear
Quantitative analysis of desmethylselegiline, methamphetamine, and amphetamine in hair and plasma from Parkinson patients on long-term selegiline medication.
    Journal of analytical toxicology, 2003, Volume: 27, Issue:3

    Topics: Aged; Aged, 80 and over; Amphetamine; Amphetamines; Antiparkinson Agents; Drug Administration Schedule; Female; Hair; Hair Color; Humans; Male; Melanins; Methamphetamine; Middle Aged; Parkinson Disease; Patient Compliance; Selegiline; Spectrophotometry

2003
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegiline.
    Journal of neural transmission. Supplementum, 1995, Volume: 45

    Topics: Aged; Amphetamine; Amphetamines; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Drug Interactions; Ergolines; Female; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline

1995

Other Studies

3 other study(ies) available for desmethylselegiline and Parkinson Disease

ArticleYear
Neuroprotection for Parkinson's disease: prospects and promises.
    Annals of neurology, 2003, Volume: 53 Suppl 3

    Topics: Amphetamines; Clinical Trials as Topic; Glial Cell Line-Derived Neurotrophic Factor; Humans; Monoamine Oxidase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Parkinson Disease; Selegiline

2003
High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users.
    Journal of analytical toxicology, 2006, Volume: 30, Issue:4

    Topics: Amphetamine; Amphetamines; Antiparkinson Agents; Chromatography, High Pressure Liquid; Hair; Humans; Methamphetamine; Parkinson Disease; Selegiline; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection

2006
Neuroprotection by (-)-deprenyl and related compounds.
    Mechanisms of ageing and development, 1999, Volume: 111, Issue:2-3

    Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidants; Parkinson Disease; Selegiline; Tumor Cells, Cultured

1999